Angiographic and interventional details
| Total (n=1008) | Non-HPR (n=665; 66%) | Individualised (n=343; 34%) | p Value | |
|---|---|---|---|---|
| Type of intervention | NS | |||
| Stent | 1000 (99%) | 661 (99%) | 339 (99%) | |
| Drug eluting | 948 (94%) | 625 (94%) | 323 (94%) | |
| Bare metal | 52 (5%) | 36 (5%) | 16 (5%) | |
| Balloon (drug eluting) | 8 (1%) | 4 (1%) | 4 (1%) | |
| Access site | NS | |||
| Femoral | 867 (86%) | 571 (86%) | 296 (86%) | |
| Radial | 117 (12%) | 77 (12%) | 40 (12%) | |
| Both | 24 (2%) | 17 (2%) | 7 (2%) | |
| Lesion location | NS | |||
| Left main | 114 (11%) | 78 (12%) | 36 (11%) | |
| Left anterior descending | 585 (58%) | 391 (59%) | 194 (57%) | |
| Left circumflex | 401 (40%) | 277 (42%) | 124 (36%) | |
| Right coronary artery | 443 (44%) | 285 (43%) | 158 (46%) | |
| Bypass graft | 18 (2%) | 12 (2%) | 6 (2%) | |
| AHA/ACC type b2/c | 739 (73%) | 490 (74%) | 249 (73%) | NS |
| Stent length total (mm; range) | 43±33 (8–241) | 44±32 (8–241) | 43±33 (8–217) | NS |
| Stents/patient (range) | 2.2±1.5 (1–12) | 2.2±1.5 (1–12) | 2.1±1.6 (1–12) | NS |
| Multivessel disease | 655 (65%) | 428 (64%) | 227 (66%) | NS |
ACC, American College of Cardiology; AHA, American Heart Association; NS, not significant.